Drug development for neglected diseases - the trouble with FDA review vouchers.

Drug development for neglected diseases - the trouble with FDA review vouchers.

Item
http://www.wikidata.org/entity/Q37318521
A systematic review and critical assessment of incentive strategies for discovery and development of novel antibioticsOne step forward, one step sideways? Expanding research capacity for neglected diseasesThe impact of the US priority review voucher on private-sector investment in global health research and developmentDriving a decade of change: HIV/AIDS, patents and access to medicines for all.An empirical review of major legislation affecting drug development: past experiences, effects, and unintended consequences.Drug and vaccine development for infectious diseases: the value of priority review vouchers.Priority review vouchers: an inefficient and dangerous way to promote neglected-disease drug development."Creating hope" and other incentives for drug development for children.Defining "innovativeness" in drug development: a systematic review.Regulators should better leverage effectiveness standards to enhance drug value.Neglected Population, Neglected Right: Children Living with HIV and the Right to Science.Why miltefosine-a life-saving drug for leishmaniasis-is unavailable to people who need it the most.Is the priority review voucher program stimulating new drug development for tropical diseases?In vitro activity of hypnophilin from Lentinus strigosus: a potential prototype for Chagas disease and leishmaniasis chemotherapy
P2860

Drug development for neglected diseases - the trouble with FDA review vouchers.

Item
http://www.wikidata.org/entity/Q37318521
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Drug development for neglected diseases - the trouble with FDA review vouchers.
@en
Drug development for neglected diseases - the trouble with FDA review vouchers.
@nl
type
label
Drug development for neglected diseases - the trouble with FDA review vouchers.
@en
Drug development for neglected diseases - the trouble with FDA review vouchers.
@nl
prefLabel
Drug development for neglected diseases - the trouble with FDA review vouchers.
@en
Drug development for neglected diseases - the trouble with FDA review vouchers.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Drug development for neglected diseases - the trouble with FDA review vouchers
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698